Olmesartan Medoxomil
Olmesartan medoxomil and hydrochlorothiazide is indicated for the treatment of hypertension, to lower blood pressure. Olmesartan medoxomil and hydrochlorothiazide is not indicated for the initial therapy of hypertension [see Dosage and Administration (2) ] .
United States
$8
per month
India
$0
per month
You save
−96%save $7/mo · 96% cheaper
3.5M US scripts/yr$26.1M potential annual savings$27.1M US spend/yr
Drag to rotate · 3D structureC29H30N6O6
SMILES: CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O
Compare the price
US price$8per month
India price$0per month
You save$796% less
Based on 30 units per month. US $0.26 vs India $0.01 per unit.
Total over 1 periodSave $7$8 → $0
The bigger picture
Olmesartan Medoxomil is filled about 3.5M times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$27.1M
If sourced from India
$1.1M
Potential annual savings
$26.1M
−96%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.